Therapeutic strategies targeting CXCR2, C-C motif chemokine receptor (CCR)2, colony stimulating factor 1 receptor (CSF1R), PI3K-γ and STAT3 signaling pathways have also shown potential in inhibiting the immunosuppressive and inflammatory effects of myeloid-derived immune cells in cancers (249). Here, CSF1R is linked to cancer.